Jay Berzofsky

Branch Chief

National Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jay Berzofsky is the Branch Chief at the National Cancer Institute, United States. His research primarily focuses on cancer immunotherapy, with recent articles exploring topics such as T cell exhaustion, dendritic cell-based cancer vaccines, and targeted therapies for solid tumors. He has also investigated immune responses related to SARS-CoV-2 and HIV-1, contributing to the understanding of vaccine efficacy and immune correlates of protection.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Francesca Chiodi

Professor in Host-Parasite Interaction

Karolinska Institutet

SWEDEN

View details

Katherine Goldfarbmuren

National Institutes of Health

UNITED STATES

View details

Elzbieta Sarnowska

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Heather Gibson

Assistant Professor

Wayne State University

UNITED STATES

View details

Hoyoung Maeng

National Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jay Berzofsky

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Cancer cells accelerate exhaustion of persistently activated mouse CD4 + T cells

High Levels of Endogenous Omega-3 Fatty Acids Promote Dendritic Cell Antigen Presentation and Improve Dendritic Cell–Based Cancer Vaccine Efficacy in Mice

Enhancing DC cancer vaccine by allogeneic MHC class II expression and Treg depletion

PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors

Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization

SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy

Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization

Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity

High Sensitivity Protein Gel Electrophoresis Label Compatible with Mass-Spectrometry

Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus

Collaborators (5)

Francesca Chiodi

Katherine Goldfarbmuren

Elzbieta Sarnowska

Heather Gibson

Hoyoung Maeng

Make your next move.